EUVIMEDEUVIMED entdecken
Crossref

A Design of mRNA-Based COVID-19 Vaccine Through Fuzzy Neural Network

Farnaz Sabahi

IEEE/ACM Transactions on Computational Biology and Bioinformatics · 2023

DOI: 10.1109/tcbb.2023.3309650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2023. Verfasst von Farnaz Sabahi. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The worldwide effort to develop a vaccine against SARS-CoV-2 has led to a revolution in vaccinology by introducing a completely new class of vaccines messenger RNA (mRNA) vaccine. The mRNA-based vaccine is a singular molecule made in the lab that teaches the cells to produce an antigen to trigger the immune response against the fake infection. However, new variants of SARS-CoV-2 may consist of an unprecedented set of genetic mutations including a sampling of earlier variants in addition to the other unknown mutations on the spike protein that may bind a part of the virus to human cells like a grappling hook. A common paradigm in designing a vaccine is to create a fixed architecture in the hope that it can make connections between the vaccine and mutations. In this paper, we propose a COVID-19 RNA-based vaccine in four modules: SARS-CoV-2 profile, mRNA-based vaccine design, interaction box, and neural codon optimization. We use epitopes' perception to collectively analyze mutations for designing mRNA-based vaccines and optimize the vaccine through neural codon optimization. In the proposed vaccine, the structural variation of the inhibitor is changed with the interaction of COVID-19 variants. To evaluate, the proposed vaccine is applied to the real data set. The results demonstrate that the proposed vaccine can provide high levels of protection against various virus mutations in comparison. Even with the challenging New3 mutation, the proposed vaccine still provided a good 78% protection with two doses of vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19HumansRNA, MessengerSARS-CoV-2Neural Networks, ComputerCodon

Substanzen

COVID-19 VaccinesRNA, MessengerCodon

Zitieren

APA

Sabahi, F. (2023). A Design of mRNA-Based COVID-19 Vaccine Through Fuzzy Neural Network. IEEE/ACM Transactions on Computational Biology and Bioinformatics. https://doi.org/10.1109/tcbb.2023.3309650

Vancouver

Sabahi F. A Design of mRNA-Based COVID-19 Vaccine Through Fuzzy Neural Network. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 2023. doi:10.1109/tcbb.2023.3309650

BibTeX
@article{Sabahi2023,
  author = {Sabahi, Farnaz},
  title = {A Design of mRNA-Based COVID-19 Vaccine Through Fuzzy Neural Network},
  journal = {IEEE/ACM Transactions on Computational Biology and Bioinformatics},
  year = {2023},
  doi = {10.1109/tcbb.2023.3309650}
}
Kostenlos starten →